Target type: biologicalprocess
The chemical reactions and pathways resulting in the formation of a nucleoside monophosphate, a compound consisting of a nucleobase linked to a deoxyribose or ribose sugar esterified with phosphate on the sugar. [GOC:go_curators, ISBN:0198506732]
Nucleoside monophosphate biosynthesis is a fundamental biological process responsible for the creation of nucleoside monophosphates (NMPs), the building blocks of DNA and RNA. These building blocks are essential for various cellular functions including genetic information storage, protein synthesis, and energy transfer. The process involves a series of enzymatic reactions that synthesize NMPs from simpler precursors like amino acids, carbohydrates, and one-carbon units.
The biosynthesis of NMPs can be divided into two main pathways:
1. **De novo synthesis:** This pathway involves the construction of NMPs from scratch using simple precursors. In the case of purine biosynthesis, the pathway starts with the formation of inosine monophosphate (IMP), a precursor for both adenosine monophosphate (AMP) and guanosine monophosphate (GMP). The biosynthesis of pyrimidines involves the creation of uridine monophosphate (UMP), which is then converted into cytidine monophosphate (CMP).
2. **Salvage pathway:** This pathway utilizes pre-existing purine and pyrimidine bases or nucleosides to generate NMPs. This pathway plays an important role in recycling nucleotides released during DNA and RNA degradation.
The specific enzymes involved in nucleoside monophosphate biosynthesis vary depending on the organism and the specific NMP being produced. However, some common enzymes include:
* **Phosphoribosyl pyrophosphate synthetase (PRPP synthetase):** Catalyzes the formation of phosphoribosyl pyrophosphate (PRPP), an essential intermediate in both de novo and salvage pathways.
* **Amidophosphoribosyltransferase (ATCase):** Converts PRPP to 5-phosphoribosyl-1-amine (PRA), a key intermediate in purine biosynthesis.
* **Glutamine amidotransferase:** Converts glutamine to ammonia, which is used in various steps of purine and pyrimidine biosynthesis.
* **Thymidylate synthase:** Catalyzes the conversion of deoxyuridine monophosphate (dUMP) to deoxythymidine monophosphate (dTMP), an essential component of DNA.
The regulation of nucleoside monophosphate biosynthesis is complex and involves feedback mechanisms that ensure the appropriate levels of nucleotides are available for cellular processes. These mechanisms are crucial for maintaining genome stability and preventing the accumulation of toxic intermediates.
In summary, nucleoside monophosphate biosynthesis is a crucial process for all living organisms, ensuring the production of essential building blocks for DNA, RNA, and other vital cellular components.'
"
Protein | Definition | Taxonomy |
---|---|---|
Ectonucleoside triphosphate diphosphohydrolase 8 | An ectonucleoside triphosphate diphosphohydrolase 8 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q5MY95] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
suramin | suramin : A member of the class of phenylureas that is urea in which each of the amino groups has been substituted by a 3-({2-methyl-5-[(4,6,8-trisulfo-1-naphthyl)carbamoyl]phenyl}carbamoyl)phenyl group. An activator of both the rabbit skeletal muscle RyR1 and sheep cardiac RyR2 isoform ryanodine receptor channels, it has been used for the treatment of human African trypanosomiasis for over 100 years. Suramin: A polyanionic compound with an unknown mechanism of action. It is used parenterally in the treatment of African trypanosomiasis and it has been used clinically with diethylcarbamazine to kill the adult Onchocerca. (From AMA Drug Evaluations Annual, 1992, p1643) It has also been shown to have potent antineoplastic properties. | naphthalenesulfonic acid; phenylureas; secondary carboxamide | angiogenesis inhibitor; antinematodal drug; antineoplastic agent; apoptosis inhibitor; EC 2.7.11.13 (protein kinase C) inhibitor; GABA antagonist; GABA-gated chloride channel antagonist; purinergic receptor P2 antagonist; ryanodine receptor agonist; trypanocidal drug |